ATLASATLAS fair value
$99.10
Above fair value · 147% premium
Range: $72–$141Fair valuePrice
Ascendis Pharma A/S (ASND)
Ascendis Pharma A/S stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$245.15▲ +0.73%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Ascendis Pharma A/S in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Ascendis Pharma A/S
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Ascendis Pharma A/S's fair value at about $99.10 per share (reasonable range: $72.22 to $140.51). At $245.15, the stock trades 147% above it.
It is calculated with a discounted cash-flow model. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Ascendis Pharma A/S a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $230.06 and $261.30; in 9 out of 10, between $205.50 and $292.53. Estimated annual volatility is 34%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $15.0B
- P/E ratio
- 17.8
- 52-week high
- $282.15
- 52-week low
- $188.07
- Revenue (12 months)
- $1.2B
- Revenue growth (YoY)
- +66.5%
- Gross margin
- 86.8%
- Operating margin
- -18.9%
- Net margin
- -31.7%
- Return on equity
- 118.8%
- Free cash flow (12 months)
- $14.5M
- Beta
- 0.00
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Ascendis Pharma A/S sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks ASND has traded between $188.07 and $282.15. Today it is 13.1% below that high and 30% above its low.
On the business: revenue grew 66.5% year over year; net margin is 31.7%; it trades at 17.8 times earnings.
Its beta is 0.00: it tends to move less than the market.
About the company
Ascendis Pharma A/S is a global biopharmaceutical company focused on developing and commercializing therapies for rare endocrine diseases and other serious chronic conditions.
Want to see everything about Ascendis Pharma A/S?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Ascendis Pharma A/S (ASND) fair value?
About $99.10 per share according to ATLAS (reasonable range: $72.22 to $140.51). With the stock at $245.15, it is 147% above it.
What is the chance ASND goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, ASND ends the month between $230.06 and $261.30.
How big is Ascendis Pharma A/S and what is its P/E ratio?
Ascendis Pharma A/S's market capitalization is $15.0B. Its price-to-earnings (P/E) ratio is 17.8: you pay $17.8 for each $1 of yearly earnings.
How volatile is ASND?
ATLAS estimates annual volatility at 34%. In a typical month, half of the outcomes end between $230.06 and $261.30.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer